Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 121 AL 135

Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta-analysis of Clinical Trials

Zeng L, Zou Y, Kong L, Wang N, Wang Q, Wang L, Cao Y, Wang K, Chen Y, Mi S, Zhao W, Wu H, Cheng S, Xu W, Liang W.

Phytother Res. 2015 Dec;29(12):1843-57. doi: 10.1002/ptr.5481. Epub 2015 Oct 6.

Towards prevention and therapy of Alzheimer's disease

Pasinetti GM.

Mol Aspects Med. 2015 Jun-Oct;43-44:1-2. doi: 10.1016/j.mam.2015.09.001.

Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors

Kračmarová A, Drtinová L, Pohanka M.

Acta Medica (Hradec Kralove). 2015;58(2):37-42. doi: 10.14712/18059694.2015.91.

Nicotinic Cholinergic Mechanisms in Alzheimer's Disease

Shen J, Wu J.

Int Rev Neurobiol. 2015;124:275-92. doi: 10.1016/bs.irn.2015.08.002. Epub 2015 Sep 26.

Restoring calcium homeostasis to treat Alzheimer's disease: a future perspective

Popugaeva E, Vlasova OL, Bezprozvanny I.

Neurodegener Dis Manag. 2015 Oct;5(5):395-8. doi: 10.2217/nmt.15.36. Epub 2015 Oct 19.

Neurorestoratologic Strategies and Mechanisms in the Nervous System

Chen L, Ao Q, Sharma HS, Wang A, Feng S.

Biomed Res Int. 2015;2015:163170. doi: 10.1155/2015/163170. Epub 2015 Sep 29.

The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer's disease: a systematic review

Sheng C, Peng W, Xia ZA, Wang Y, Chen Z, Su N, Wang Z.

BMC Complement Altern Med. 2015 Oct 24;15:386. doi: 10.1186/s12906-015-0894-y.

Benefits and risks of add-on therapies for Alzheimer's disease

Magierski R, Sobow T.

Neurodegener Dis Manag. 2015 Oct;5(5):445-62. doi: 10.2217/nmt.15.39. Epub 2015 Oct 30.

Memantine ER/Donepezil: A Review in Alzheimer's Disease

Greig SL.

CNS Drugs. 2015 Nov;29(11):963-70. doi: 10.1007/s40263-015-0287-2.

Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease

Wicke K, Haupt A, Bespalov A.

Expert Opin Investig Drugs. 2015;24(12):1515-28. doi: 10.1517/13543784.2015.1102884. Epub 2015 Nov 7.

Alzheimer's Disease: Mechanism and Approach to Cell Therapy

Amemori T, Jendelova P, Ruzicka J, Urdzikova LM, Sykova E.

Int J Mol Sci. 2015 Nov 4;16(11):26417-51. doi: 10.3390/ijms161125961.

Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease

Balmus IM, Ciobica A, Negura A, Negura L, Anton E.

Psychiatr Danub. 2015 Dec;27(4):338-45.

Current and Future Treatments for Alzheimer Disease

Small GW, Greenfield S.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1101-5. doi: 10.1016/j.jagp.2015.08.006. Epub 2015 Sep 9.

Real-world evaluation of compliance and preference in Alzheimer's disease treatment

Pai MC, Aref H, Bassil N, Kandiah N, Lee JH, Srinivasan AV, diTommaso S, Yuksel O.

Clin Interv Aging. 2015 Nov 3;10:1779-87. doi: 10.2147/CIA.S85319. eCollection 2015.

Herbal medicine Davaie Loban in mild to moderate Alzheimer's disease: A 12-week randomized double-blind placebo-controlled clinical trial

Tajadini H, Saifadini R, Choopani R, Mehrabani M, Kamalinejad M, Haghdoost AA.

Complement Ther Med. 2015 Dec;23(6):767-72. doi: 10.1016/j.ctim.2015.06.009. Epub 2015 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias